Skip to main content
Australian Prescriber logoLink to Australian Prescriber
letter
. 2015 Oct 1;38(5):150. doi: 10.18773/austprescr.2015.061

Warfarin and beetroot

Louise Vanpraag 1
PMCID: PMC4657307  PMID: 26648649

I was interested to read your article ‘How to manage warfarin therapy’ (Aust Prescr 2015;38:44-8). In the article and subsequent online quiz, it mentions beetroot as being one of the foods that can affect INR, which I found rather unusual. After having worked as a senior pharmacist on a cardiothoracic ward for a number of years, I have counselled countless patients on warfarin and factors that can influence INR and I have never heard of beetroot being one of them. After doing some of my own research, I came across the vitamin K contents of beetroot, which was listed to be approximately 0.3 micrograms per 100 g in comparison with spinach 540 micrograms per 100 g.

Consequently, I believe that consuming beetroot while taking warfarin would have an insignificant effect on INR compared to other foods. I also noted in the quiz that vitamin C was listed as not affecting INR and, although there is limited evidence, there are a number of case reports of vitamin C at high doses affecting INR. Vitamin C is also listed in the Western Australian Department of Health’s Living with Warfarin: Information for Patients,1 so I believe that it is worth mentioning as something that could possibly affect INR.

REFERENCE

Aust Prescr. 2015 Oct 1;38(5):150.

Authors’ response

Philip A Tideman 1,2, Rosy Tirimacco 1,2, Andrew St John 1, Gregory W Roberts 3

Philip A Tideman, Rosy Tirimacco, Andrew St John and Gregory W Roberts, authors of the article, comment:

Louise Vanpraag rightly points out that the beetroot bulb is a negligible source of vitamin K. It was our oversight in not explicitly naming the beetroot leaves as the rich source of vitamin K rather than the bulb.

While there have been two separate case reports of a possible interaction between high doses of vitamin C and warfarin causing an elevated INR, three separate crossover trials using daily vitamin C doses of 1–10 g for periods of one week to six months have failed to reveal an interaction.


Articles from Australian Prescriber are provided here courtesy of Therapeutic Guidelines Ltd

RESOURCES